Stock Earnings
Positive sentiment towards CRSP reflected by a fall of -8.94% in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s recently made public that its Director Treco Douglas A acquired Company’s shares for reported $1.14 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s recent filing unveils that its Director Treco Douglas A acquired Company’s shares for reported $1.14 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s filing revealed that its Director George Simeon acquired Company’s shares for reported $51.5 million on Jul 16
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s filing revealed that its Director George Simeon acquired Company’s shares for reported $51.5 million on Jul 16